Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Imperial Bank of Commerce
CM
|
+$593M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$578M |
| 3 |
JPMorgan Chase
JPM
|
+$507M |
| 4 |
Canadian Natural Resources
CNQ
|
+$440M |
| 5 |
Air Products & Chemicals
APD
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.43B |
| 2 |
Morgan Stanley
MS
|
+$915M |
| 3 |
Microsoft
MSFT
|
+$838M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$833M |
| 5 |
NVIDIA
NVDA
|
+$790M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.59% |
| 2 | Technology | 15.8% |
| 3 | Industrials | 8.04% |
| 4 | Healthcare | 7.25% |
| 5 | Consumer Discretionary | 6.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXDR
5476
Nextdoor Holdings
NXDR
$998M
| $46K | ﹤0.01% |
20,067
-27,246
| -58% | -$50.9K |
|
5477
Kymera Therapeutics
KYMR
$9.76B
| $46K | ﹤0.01% |
1,136
-10,718
| -90% | -$383K |
|
5478
ProShares K-1 Free Crude Oil Strategy ETF
OILK
$234M
| $46K | ﹤0.01% |
953
+791
| +488% | +$35.3K |
|
5479
Zentalis Pharmaceuticals
ZNTL
$255M
| $46K | ﹤0.01% |
2,882
-14,645
| -84% | -$201K |
|
|
INBX
5480
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $46K | ﹤0.01% |
1,324
-14,669
| -92% | -$535K |
|
5481
AllianzIM U.S. Equity Buffer20 Apr ETF
APRW
$202M
| $45K | ﹤0.01% |
1,482
| – | – |
|
5482
Cadre Holdings
CDRE
$1.46B
| $45K | ﹤0.01% |
1,235
-4,248
| -77% | -$148K |
|
|
EU
5483
enCore Energy
EU
$235M
| $45K | ﹤0.01% |
10,329
-50,900
| -83% | -$216K |
|
5484
HealthStream
HSTM
$846M
| $45K | ﹤0.01% |
1,690
-6,541
| -79% | -$175K |
|
|
FDIQ
5485
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$48.7M
| $45K | ﹤0.01% |
880
-557
| -39% | -$28.2K |
|
|
QIPT
5486
DELISTED
Quipt Home Medical
QIPT
| $45K | ﹤0.01% |
10,355
-12,543
| -55% | -$56.7K |
|
5487
ARKO Corp
ARKO
$544M
| $44K | ﹤0.01% |
7,730
-13,552
| -64% | -$98.9K |
|
|
GP
5488
GreenPower Motor Co
GP
$13M
| $44K | ﹤0.01% |
2,221
+778
| +54% | +$19.2K |
|
5489
Marcus & Millichap
MMI
$1.2B
| $44K | ﹤0.01% |
1,293
-7,830
| -86% | -$287K |
|
5490
Cartesian Therapeutics
RNAC
$267M
| $44K | ﹤0.01% |
2,218
-1,622
| -42% | -$34.4K |
|
5491
Sight Sciences
SGHT
$448M
| $44K | ﹤0.01% |
8,144
-4,595
| -36% | -$21.6K |
|
5492
SIGA Technologies
SIGA
$216M
| $44K | ﹤0.01% |
5,111
-8,467
| -62% | -$48.3K |
|
5493
Target Hospitality
TH
$1.74B
| $44K | ﹤0.01% |
4,050
-9,209
| -69% | -$86.5K |
|
5494
Xencor
XNCR
$1.74B
| $44K | ﹤0.01% |
1,969
-16,398
| -89% | -$354K |
|
|
ACCD
5495
DELISTED
Accolade Inc
ACCD
| $44K | ﹤0.01% |
4,237
-20,258
| -83% | -$230K |
|
|
GRTS
5496
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $44K | ﹤0.01% |
17,041
-27,357
| -62% | -$66.8K |
|
5497
Amplify AI Powered Equity ETF
AIEQ
$125M
| $43K | ﹤0.01% |
1,170
-479
| -29% | -$16.9K |
|
|
ALX
5498
Alexander's
ALX
$1.38B
| $43K | ﹤0.01% |
198
-616
| -76% | -$134K |
|
5499
Anterix
ATEX
$1.79B
| $43K | ﹤0.01% |
1,277
-2,603
| -67% | -$87.5K |
|
5500
Actinium Pharmaceuticals
ATNM
$32.6M
| $43K | ﹤0.01% |
5,488
-8,046
| -59% | -$51.7K |
|
Similar funds
Royal Bank of Canada's Q1 2024 Portfolio in Review
As of Q1 2024, Royal Bank of Canada held 7,910 positions worth $436B, up 1.8% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada withdrew a net $22.8B in Q1 2024, closing 495 positions and reducing 4,132 holdings. Its most notable exit was Splunk Inc, an estimated $93.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
Against the trend, Royal Bank of Canada opened a new position in Flutter Entertainment worth $56.3M.
- Royal Bank of Canada's largest Q1 2024 buy was Flutter Entertainment: 285,002 shares worth $56.3M.
- Royal Bank of Canada added most to Canadian Imperial Bank of Commerce in Q1 2024, an estimated $593M increase.
- Royal Bank of Canada's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.43B.
- Royal Bank of Canada fully exited Splunk Inc in Q1 2024, selling an estimated $93.4M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $436B portfolio in Q1 2024.
- Royal Bank of Canada opened 367 new positions and closed 495 in Q1 2024.
- Royal Bank of Canada's portfolio value rose 1.8% quarter-over-quarter to $436B.
Based on Royal Bank of Canada's 13F filing for Q1 2024, filed 15 May 2024.